Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 676 AL 690

A Review of the Catalytic Mechanism of Human Manganese Superoxide Dismutase

Azadmanesh J, Borgstahl GEO.

Antioxidants (Basel). 2018 Jan 30;7(2):25. doi: 10.3390/antiox7020025.

LRRK2 Phosphorylation: Behind the Scenes

De Wit T, Baekelandt V, Lobbestael E.

Neuroscientist. 2018 Oct;24(5):486-500. doi: 10.1177/1073858418756309. Epub 2018 Jan 31.

High-intensity focused ultrasound: past, present, and future in neurosurgery

Quadri SA, Waqas M, Khan I, Khan MA, Suriya SS, Farooqui M, Fiani B.

Neurosurg Focus. 2018 Feb;44(2):E16. doi: 10.3171/2017.11.FOCUS17610.

Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease: a randomised blinded evaluation

Blomstedt P, Stenmark Persson R, Hariz GM, Linder J, Fredricks A, Häggström B, Philipsson J, Forsgren L, Hariz M.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):710-716. doi: 10.1136/jnnp-2017-317219. Epub 2018 Jan 31.

Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential

Kashyap D, Tuli HS, Garg VK, Goel N, Bishayee A.

Mol Diagn Ther. 2018 Apr;22(2):179-201. doi: 10.1007/s40291-018-0316-1.

Towards a better understanding of the cannabinoid-related orphan receptors GPR3, GPR6, and GPR12

Morales P, Isawi I, Reggio PH.

Drug Metab Rev. 2018 Feb;50(1):74-93. doi: 10.1080/03602532.2018.1428616. Epub 2018 Feb 1.

Patient-centered integrated healthcare improves quality of life in Parkinson's disease patients: a randomized controlled trial

Eggers C, Dano R, Schill J, Fink GR, Hellmich M, Timmermann L; CPN study group.

J Neurol. 2018 Apr;265(4):764-773. doi: 10.1007/s00415-018-8761-7. Epub 2018 Feb 1.

Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review)

Guo JD, Zhao X, Li Y, Li GR, Liu XL.

Int J Mol Med. 2018 Apr;41(4):1817-1825. doi: 10.3892/ijmm.2018.3406. Epub 2018 Jan 19.

The development of biological therapies for neurological diseases: moving on from previous failures

Qosa H, Volpe DA.

Expert Opin Drug Discov. 2018 Apr;13(4):283-293. doi: 10.1080/17460441.2018.1437142. Epub 2018 Feb 7.

Sarcopenia in Parkinson Disease: Comparison of Different Criteria and Association With Disease Severity

Vetrano DL, Pisciotta MS, Laudisio A, Lo Monaco MR, Onder G, Brandi V, Fusco D, Di Capua B, Ricciardi D, Bernabei R, Zuccalà G.

J Am Med Dir Assoc. 2018 Jun;19(6):523-527. doi: 10.1016/j.jamda.2017.12.005. Epub 2018 Feb 12.

Subthalamic deep brain stimulation under general anesthesia and neurophysiological guidance while on dopaminergic medication: comparative cohort study

Asha MJ, Fisher B, Kausar J, Garratt H, Krovvidi H, Shirley C, White A, Chelvarajah R, Ughratdar I, Hodson JA, Pall H, Mitchell RD.

Acta Neurochir (Wien). 2018 Apr;160(4):823-829. doi: 10.1007/s00701-018-3473-4. Epub 2018 Feb 2.

Role of adenosine A(2A) receptors in motor control: relevance to Parkinson's disease and dyskinesia

Pinna A, Serra M, Morelli M, Simola N.

J Neural Transm (Vienna). 2018 Aug;125(8):1273-1286. doi: 10.1007/s00702-018-1848-6. Epub 2018 Feb 2.

Red man syndrome caused by vancomycin powder

Nagahama Y, VanBeek MJ, Greenlee JDW.

J Clin Neurosci. 2018 Apr;50:149-150. doi: 10.1016/j.jocn.2018.01.044. Epub 2018 Feb 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias